Therapy News and Research

RSS

Can liver cirrhosis be partially cured?

The diffusion of hepatitis C virus infection worldwide is astonishing. Liver cirrhosis is present in at least 10-20% of these infected patients, with highly increasing health care and emotional costs.

10 Oct 2007

Androgen deprivation therapy linked to increased risk of heart disease death

The use of androgen deprivation therapy to treat localized prostate cancer is associated with an increased risk of death from heart disease, according to a study published online October 9 in the Journal of the National Cancer Institute .

10 Oct 2007

Complementary medicine for chronic pain

Mr. Jones has chronic back pain. He cannot sleep, bend or stand for long periods of time because of the pain. He cannot lose weight because the pain keeps him from exercising.

10 Oct 2007

Interleukin-8, key marker for colorectal cancer treatment

Colorectal cancer (CRC) is currently one of the three most frequent malignancies in Western industrial nations.

10 Oct 2007

Intensity modulated radiation therapy better for sparing bladder when treating prostate cancer

When treating early-stage prostate cancer, intensity modulated radiation therapy (IMRT) spares the bladder significantly more from direct radiation when compared to 3-D conformal proton therapy (3D-CPT), but the amount of rectal sparing is similar with both treatments, according to a study released in the October issue of the International Journal for Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.

10 Oct 2007

$Accentia announces investigational new drug application for Revimmune for refractory MS$

Accentia announces investigational new drug application for Revimmune for refractory MS

Accentia Biopharmaceuticals has announced that it met with the Food and Drug Administration (FDA) on September 26, 2007 for a scheduled pre-Investigational New Drug (pre-IND) meeting on Revimmune.

10 Oct 2007

African-American women less likely to have adjuvant cancer therapy than white women

A new study finds that white women more frequently take more of the life-prolonging supplemental therapies used to treat breast cancer than African-American women.

9 Oct 2007

Surgery may offer best chance of long-term prostate cancer survival

A study from Switzerland suggests that men who have surgery for prostate cancer appear less likely to die of the disease within 10 years than men who choose other treatment options, especially if they are younger or have cancers with certain tumor cell characteristics, according to a report in the Oct. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

9 Oct 2007

Surgery for prostate cancer appear to offer greatest survival chance

9 Oct 2007

Injectable antibody reverses cognitive deficits in mice

A special protein can be injected into the body to reverse learning problems in mice that have an animal version of Alzheimer's disease, Saint Louis University researchers have found.

9 Oct 2007

One injection of gene therapy spreads through brain in animal study

By targeting a site in a mouse brain well connected to other areas, researchers successfully delivered a beneficial gene to the entire brain - after one injection of gene therapy.

9 Oct 2007

Sir Martin Evans wins Nobel prize for stem cell research

Medical Research Council funded scientist Sir Martin Evans, has been awarded the Nobel Prize in Physiology or Medicine for 2007 alongside Mario R. Capecchi and Oliver Smithies for their discoveries of "principles for introducing specific gene modifications in mice by the use of embryonic stem cells".

9 Oct 2007

HAART stops brain damage caused by HIV

A combination of drugs widely used to treat infections caused by HIV appears to stop brain damage caused by the virus as well, according to a study published in the October 9, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.

9 Oct 2007

Treatment for breast cancer differs between African-American women and white women

The study found that, among patients with breast cancer that had spread to the lymph nodes, African-Americans were less likely to have adjuvant cancer therapy than white women. In this clinical group, white women were almost five times more likely to take Tamoxifen, a widely-used cancer therapy medication, and over three times more likely to have chemotherapy.

9 Oct 2007

Small papillary thyroid cancers are NOT clinically insignificant

Patients with micropapillary thyroid cancer - small tumors equal to or less than 1 centimeter—and tumors even smaller, less than 1 millimeter (mm - are more common and not without a risk as previously thought, according to a new study presented at the 78th Annual Meeting of the American Thyroid Association (ATA) in New York.

8 Oct 2007

Genes that increase rheumatoid arthritis risk found

Researchers in the United States and Sweden have identified a genetic region associated with increased risk of rheumatoid arthritis (RA), a chronic and debilitating inflammatory disease of the joints that affects an estimated 2.1 million Americans.

8 Oct 2007

Pay-for-performance project to improve cardiovascular care

Thousands of heart patients in the Greater New York region will receive top quality, comprehensive cardiac care in an innovative cardiovascular program in which physicians at a major academic medical center will receive incentive payments based on 60 performance measures for outpatient and inpatient care.

8 Oct 2007

Clinical trial for lab-grown neo-bladder to help spinal cord injury patients

Urologists at Thomas Jefferson University Hospital are studying whether a neo-bladder construct grown from a patient's own cells can improve bladder function for adult spinal cord injury patients.

8 Oct 2007

Fraunhofer pharmaceutical agent speeds drug development

It takes a great deal of time and money to develop a new drug. At Biotechnica in Hanover from October 9 to 11, the Fraunhofer Life Sciences Alliance will demonstrate how a pharmaceutical agent can make its way more quickly from the research laboratory to the pharmacy.

8 Oct 2007

Thalidomide therapy helps elderly myeloma patients live longer

The drug thalidomide is making a comeback as a cancer fighting therapy and has been successfully used along with standard therapy to treat the blood cancer myeloma.

7 Oct 2007